New York, U.S. | Xinhua | U.S. pharmaceutical giant Pfizer Inc. Tuesday said final results show that its novel COVID-19 oral antiviral tablets could reduce risk of hospitalization or death by close to 90 percent for high-risk patients. The results, based on an analysis of over 2,000 patients in a phase …
Read More »Booster shot provides protection against Omicron: Pfizer
New York, U.S. | Xinhua | A booster shot of COVID-19 vaccine would provide enough protection against the Omicron variant while two doses may not be sufficient, said COVID-19 vaccine developers Pfizer Inc. and BioNTech SE on Wednesday. Three doses of the Pfizer-BioNTech COVID-19 vaccine would generate sufficient serum antibodies to …
Read More »BioNTech/Pfizer says booster vaccination increases COVID-19 protection to 95.6 pct
Berlin, Germany | Xinhua | A booster vaccination with the COVID-19 vaccine of BioNTech and Pfizer increased protection to up to 95.6 percent, the companies announced on Thursday. A randomized, controlled phase III study of more than 10,000 people aged 16 years and older found that booster vaccinations with the Comirnaty …
Read More »